Skip to main content

Table 5 Adherence to clinical standards for management of obstetric complications

From: Severe maternal outcomes and quality of care at district hospitals in Rwanda– a multicentre prospective case-control study

Use of uterotonics for Prevention of postpartum haemorrhage
 Target population women giving birth at DH N1 = 511a
 Oxytocin 485 (94.9%)
 Misoprostol 7 (1.4%)
 All uterotonics 492 (96.3%)
Treatment of PPH
 Target population women severe PPH N2 = 58
 Oxytocin 38 (65.5%)
 Oxytocin/Removal of retained placenta 7 (12.1%)
 Oxytocin/Misoprostol 3 (5.2%)
 Misoprostol 1 (1.7%)
 Hysterectomy 6 (10.3%)
Use of anticonvulsants
 Target population women with severe (pre-) eclampsia N3 = 19
 Magnesium sulfate 18 (94.7%)
 Diazepam 1 (5.3%)
Prevention of caesarean section /laparotomy related infection
 Target population undergoing Caesarean section/laparotomy N4 = 300b
 Prophylactic antibiotics 456 (98.6%)
Treatment of sepsis
 Target population women with sepsis N5 = 15
 Parenteral therapeutic antibiotics 15 (100%)
  1. a511 cases among SMO and controls gave birth at district hospital
  2. b249 cases of caesarean sections (Table 1) plus 51 cases of laparotomy